RNA molecules found in urine, tissue that detect prostate cancer

9 octubre 2014

Potential biomarkers may pave way to a more sensitive, specific, and non-invasive prostate cancer screening assay, according to a report. Today, prostate cancer is primarily detected and monitored by testing for high concentrations of prostate-specific antigen (PSA) in blood samples. The researchers believe that they have identified a group of RNA molecules that hold the potential for serving as better prognostic markers for prostate cancer.